Skip to main content
NIH funding notice RFA-TR-16-001

Pre-clinical Research Based on Existing Repurposing Tools

Closed on January 13, 2016.

Posted
October 21, 2015
Close date
January 13, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
14
14 new
Median first-year cost
$321,583
$4,311,937 in all
Institutions
13
14 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2
  2. ALLEGHENY-SINGER RESEARCH INSTITUTE1
  3. BETH ISRAEL DEACONESS MEDICAL CENTER1
  4. COLLABORATIONS PHARMACEUTICALS, INC.1
  5. EMORY UNIVERSITY1

and 8 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZTR1 DPI-2 (01))13
  2. ZTR1-SRC(99)1
14 awards under RFA-TR-16-001 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2017Application of a Repurposed FDA Approved Drug as a Local Osteogenic Agent1R21TR001751-01Sangadala, SreedharaWillett, Nick JEMORY UNIVERSITY, GAFirst-year cost $224,350Study section ZTR1
FY2017Targeting glucose metabolism for the treatment of Hepatocellular Carcinoma1R21TR001743-01Chen, BinUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CAFirst-year cost $108,622Study section ZTR1
FY2016Biomedical Data Translator Technical Feasibility Assessment and Architecture Design1OT3TR002020-01Ahalt, Stanley CarltonTropsha, AlexanderUNIV OF NORTH CAROLINA CHAPEL HILL, NCFirst-year cost $454,336Study section ZTR1
FY2016Repurposing misoprostol for Clostridium difficile colitis as identified by PheWAS1R21TR001723-01Aronoff, David MVANDERBILT UNIVERSITY MEDICAL CENTER, TNFirst-year cost $355,500Study section ZTR1
FY2016Pre-clinical evaluation of a neutrophil elastase inhibitor for the treatment of inflammatory bowel disease1R21TR001753-01Kokkotou, Efi G.BETH ISRAEL DEACONESS MEDICAL CENTER, MAFirst-year cost $346,000Study section ZTR1
FY2016CXCR2 antagonism in the immunometabolic regulation of type 2 diabetes1R21TR001728-01Giannoukakis, NickALLEGHENY-SINGER RESEARCH INSTITUTE, PAFirst-year cost $341,528Study section ZTR1
FY2016Network-driven drug repurposing approaches to treat coronary artery disease1R21TR001739-01Bjorkegren, Johan MGiannarelli, ChiaraICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NYFirst-year cost $339,000Study section ZTR1
FY2016Anti-virulence drug repurposing using structural systems pharmacology1R21TR001722-01Xie, LeiHUNTER COLLEGE, NYFirst-year cost $328,384Study section ZTR1
FY2016Quantum model repurposing of cethromycin for liver stage malaria1R21TR001737-01Sullivan, David JosephJOHNS HOPKINS UNIVERSITY, MDFirst-year cost $326,166Study section ZTR1
FY2016Drug Repositioning in Diabetic Nephropathy1R21TR001761-01Sarwal, Minnie MUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CAFirst-year cost $317,000Study section ZTR1
FY2016Repurposing lesogaberan for the treatment of type 1 diabetes1R21TR001742-01Kaufman, DanielUNIVERSITY OF CALIFORNIA LOS ANGELES, CAFirst-year cost $308,000Study section ZTR1
FY2016Ketorolac and Related NSAIDs for Targeting Rho-family GTPases in Ovarian Cancer1R21TR001731-01Wandinger-Ness, AngelaUNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NMFirst-year cost $303,000Study section ZTR1
FY2016Repurposing pyronaridine as a treatment for the Ebola virus1R21TR001718-01Davey, Robert AEkins, SeanCOLLABORATIONS PHARMACEUTICALS, INC., NCFirst-year cost $288,801Study section ZTR1
FY2016Therapeutic Repurposing of Benserazide for Colon Cancer1R21TR001734-01Szabo, CsabaUNIVERSITY OF TEXAS MED BR GALVESTON, TXFirst-year cost $271,250Study section ZTR1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-TR-16-001: Pre-clinical Research Based on Existing Repurposing Tools | ScienceDex